[Use of cholinesterase inhibitors in postoperative care].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004064:Digestive System / Q000187:drug effects / Q000503:physiopathology; D004562:Electrocardiography; D004568:Electrodiagnosis; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007813:Laparotomy; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D011183:Postoperative Complications / Q000188:drug therapy / Q000517:prevention & control; D011729:Pyridostigmine Bromide / Q000494:pharmacology / Q000627:therapeutic use*; D013016:Sound; D013997:Time Factors; D001743:Urinary Bladder / Q000503:physiopathology; D014555:Urination Disorders / Q000188:drug therapy; D014839:Vomiting / Q000209:etiology
D002800:Cholinesterase Inhibitors; D011729:Pyridostigmine Bromide
Zur Anwendung von Cholinesterasehemmern in der postoperativen Phase.